SB Bioseutica Companies

BIOSEUTICA BV has been created in 2008 after the merger of Neova Technologies Inc. and KD-PHARMA GmbH. In 2013 a majority stake of KD-PHARMA GmbH has been sold to a german private equity.

Neova Technologies Inc. draws on almost thirty years of expertise in bioseparation and protein fractionation, building its international reputation on quality and service.

Led by an international management team, Bioseutica’s organization allows the company to efficiently and consistently deliver quality products, custom designed solutions and customer service to international clients across the world.

Eggs are a rich natural source of proteins with diverse properties and functionality. All proteins in an egg work together to ensure supply of the developing chicken with nutrients for growths and to ensure protection from pathogens such as bacteria or viruses. 

Lysozyme and our other Ovoproteins are extracted from naturally occurring hen egg-white, a non-GMO and renewable protein source.

As a leader in the pharmaceutical Egg Lysozyme, Egg Proteins and Pancreatic Enzymes market, our company has extensive experience, knowledge and a long-standing track record in successfully submitting Active Substance Master Files [ASMFs] for Active Pharmaceutical Ingredients [APIs] to the major authorities worldwide. Full Chemistry Manufacturing and Control [CMC] service is provided to our partners in order to support them with the supply of registration/validation material and commercial manufacturing.